Trial · NCT04598451
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Pemphigus Vulgaris (PV) Participants Who Achieve Complete Clinical Remission (CR) on Minimal Prednisone Therapy | Efgartigimod PH20 SC | 44 | Participants | ||
| Number of Pemphigus Vulgaris (PV) Participants Who Achieve Complete Clinical Remission (CR) on Minimal Prednisone Therapy | Placebo PH20 SC | 20 | Participants | ||
| Number of Pemphigus Vulgaris (PV) and Pemphigus Foliaceus (PF) Participants Who Achieve Complete Clinical Remission (CR) on Minimal Prednisone Therapy Within 30 Weeks | Efgartigimod PH20 SC | 55 | Participants | ||
| Number of Pemphigus Vulgaris (PV) and Pemphigus Foliaceus (PF) Participants Who Achieve Complete Clinical Remission (CR) on Minimal Prednisone Therapy Within 30 Weeks | Placebo PH20 SC | 24 | Participants | ||
| Normalized Cumulative Prednisone Dose During the Treatment Period in Pemphigus Vulgaris Participants | Efgartigimod PH20 SC | 0.416 | Standard Deviation 0.215 | mg/kg/day | |
| Normalized Cumulative Prednisone Dose During the Treatment Period in Pemphigus Vulgaris Participants | Placebo PH20 SC | 0.444 | Standard Deviation 0.232 | mg/kg/day | |
| Time to Complete Clinical Remission (CR) in Pemphigus Vulgaris Participants | Efgartigimod PH20 SC | 106 | 95% Confidence Interval 79 to 161 | days | |
| Time to Complete Clinical Remission (CR) in Pemphigus Vulgaris Participants | Placebo PH20 SC | 120 | 95% Confidence Interval 85 to 188 | days | |
| Time to Disease Control (DC) in Pemphigus Vulgaris (PV) Participants | Efgartigimod PH20 SC | 16 | 95% Confidence Interval 15 to 21 | days | |
| Time to Disease Control (DC) in Pemphigus Vulgaris (PV) Participants | Placebo PH20 SC | 15 | 95% Confidence Interval 8 to 17 | days | |
| Normalized Cumulative Prednisone Dose During the Treatment Period in Pemphigus Vulgaris and Pemphigus Foliaceus Participants | Efgartigimod PH20 SC | 0.403 | Standard Deviation 0.210 | mg/kg/day | |
| Normalized Cumulative Prednisone Dose During the Treatment Period in Pemphigus Vulgaris and Pemphigus Foliaceus Participants | Placebo PH20 SC | 0.431 | Standard Deviation 0.225 | mg/kg/day | |
| Time to Complete Clinical Remission (CR) in Pemphigus Vulgaris and Pemphigus Foliaceus Participants | Efgartigimod PH20 SC | 106 | 95% Confidence Interval 84 to 142 | days | |
| Time to Complete Clinical Remission (CR) in Pemphigus Vulgaris and Pemphigus Foliaceus Participants | Placebo PH20 SC | 113 | 95% Confidence Interval 81 to 149 | days | |
| Time to Disease Control in Pemphigus Vulgaris and Pemphigus Foliaceus Participants | Efgartigimod PH20 SC | 15 | 95% Confidence Interval 15 to 17 | days | |
| Time to Disease Control in Pemphigus Vulgaris and Pemphigus Foliaceus Participants | Placebo PH20 SC | 15 | 95% Confidence Interval 9 to 16 | days |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04598451/results